Ultime notizie per OLB Gr (NASDAQ:OLB) Azioni

OLB Gr

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The Company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

The OLB Group Inc

OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) reported quarterly losses of $(1.49) per share. This is a 263.41 percent decrease over losses of $(0.41) per share from the same period last year. The company reported $3.52 million in sales this quarter. This is a 57.80 percent decrease over sales of $8.34 million the same period last year.

Earnings

News

OLB Gr Q2 EPS $(1.49) Down From $(0.41) YoY, Sales $3.52M Down From $8.34M YoY

WIIM

OLB Group shares are trading lower after the company filed for a mixed shelf offering of up to $75 million.

Offerings

OLB Group Files For Mixed Shelf Offering Up To $75M

The OLB Group, Inc., (NASDAQ:<a href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) , a diversified Fintech eCommerce merchant services provider and cryptocurrency mining enterprise, issued an open Letter to Shareholders from Chairman and CEO of OLB Group, Ronny Yakov, providing a review of a challenging 2023 and anticipated milestones for 2024.

OLB Group Chairman And CEO Issues Open Letter To Shareholders Providing A Review Of A Challenging 2023 And Anticipated Milestones For 2024

OLB Group shares are trading lower after the company reported a year-over-year decrease in its Q1 sales results.

OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) reported quarterly losses of $(0.14) per share. This is a 17.65 percent increase over losses of $(0.17) per share from the same period last year. The company reported $3.50 million in sales this quarter. This is a 47.21 percent decrease over sales of $6.62 million the same period last year.

OLB Gr Q1 EPS $(0.14) Up From $(0.17) YoY, Sales $3.50M Down From $6.62M YoY

Trading Ideas

The OLB Group Shares Resume Trade

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Shares of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) rose sharply in today's pre-market trading after the company reported better reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/05/38599545/apple-q2-earnings-beats-muted-forecast-on-services-mac-strength-installed-base-at-fresh-record-cupe">results for its second quarter</a>.
The company announced a $110-billion stock buyback program and a one-penny-per-share increase in its quarterly dividend.
Apple shares jumped 5.9% to $183.24 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Vaxxinity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAXX#NASDAQ">VAXX</a>) gained 45.8% to $0.1519 in pre-market trading after falling 9% on Thursday. Vaxxinity recently announced its intention to voluntarily delist and deregister its Class A common stock.</li>
<li>El Pollo Loco Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOCO#NASDAQ">LOCO</a>) gained 23.1% to $10.59 in pre-market trading after the company reported better-than-expected first-quarter results.</li>
<li>AXT, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXTI#NASDAQ">AXTI</a>) rose 23.8% to $3.75 in today's pre-market trading after the company reported better-than-expected first-quarter financial results.</li>
<li>Jaguar Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) jumped 20.7% to $0.3540 in pre-market trading after surging 30% on Thursday.</li>
<li>Ardelyx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARDX#NASDAQ">ARDX</a>) shares gained 19.2% to $8.09 in pre-market trading after the company reported better-than-expected first-quarter financial results.</li>
<li>OneSpan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSPN#NASDAQ">OSPN</a>) shares gained 18.6% to $13.00 in pre-market trading after the company reported better-than-expected first-quarter adjusted EPS and sales.</li>
<li>Rapid Micro Biosystems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPID#NASDAQ">RPID</a>) shares rose 16.2% to $1.15 in pre-market trading.</li>
<li>The OLB Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) shares gained 19.8% to $0.5636 in pre-market trading after gaining 12% on Thursday. The company announced its shareholders approve a 1-for-10 reverse split.</li>
<li>Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) shares rose 14.2% to $318.01 in pre-market trading after the company reported better-than-expected first-quarter financial results. Also, the company announced a $50 million milestone payment from Royalty Pharma.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>NanoVibronix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) fell 44.8% to $0.3988 in pre-market trading after gaining 7% on Thursday.</li>
<li>Sprout Social, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) shares declined 25.2% to $36.00 in pre-market trading after the company reported worse-than-expected first-quarter revenue results.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) fell 19.4% to $2.54 in pre-market trading after the company reported a year-over-year decrease on first-quarter revenue results.</li>
<li>Stem, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) shares fell 18.7% to $1.55 in pre-market trading after the company reported worse-than-expected first-quarter financial results and cut its FY24 revenue guidance.</li>
<li>Terran Orbital Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLAP#NYSE">LLAP</a>) shares fell 18.5% to $1.05 in pre-market trading fter Lockheed Martin withdrew its buyout proposal.</li>
<li>Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) fell 14% to $76.50 pre-market trading after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Trupanion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) shares declined 13% to $20.68 in pre-market trading following first-quarter results.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) shares fell 12.1% to $1.52 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
<li>Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) shares declined 10.1% to $121.92 in pre-market trading after the company lowered its full-year guidance.</li>
<li>Fortinet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) fell 8.3% to $59.81 pre-market trading after the company reported its first-quarter financial results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38606910/investor-sentiment-increases-ahead-of-jobs-report-dow-jumps-over-300-points">Investor Sentiment Increases Ahead Of Jobs Report, Dow Jumps Over 300 Points</a>

Pre-Market Outlook

Markets

Movers

AAPL

AMGN

ARDX

AXTI

BBAI

EXPE

FTNT

JAGX

LLAP

LOCO

MRIN

NAOV

OSPN

RPID

STEM

TRUP

VAXX

Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

OLB Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) shares are trading higher by 16% to $0.50 during Thursday&#8217;s session. The company announced its shareholders approved a <a href="https://www.accesswire.com/858835/the-olb-group-inc-announces-one-for-ten-reverse-stock-split#:~:text=(NASDAQ%3AOLB)%20(%22,its%20common%20stock%20on%20a">1-for-10 reverse split</a>.
The split will be effective May 6. This means that every ten pre-split shares of common stock will be combined into one share. The company&#8217;s issued and outstanding common stock will be reduced from approximately 18.1 million shares to around 1.8 million shares. 
OLB says the purpose of the reverse split is to increase the market price per share to maintain its Nasdaq listing. No fractional shares will be issued, and any resulting fractional shares will be converted into cash.
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/05/38584705/federal-reserve-takes-cautious-stand-on-inflation-powell-signals-preference-for-r">Federal Reserve Takes Cautious Stand On Inflation, Powell Signals Preference For Rate Cuts Over Hikes</a>
<h2 class="wp-block-heading">How To Buy OLB Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in OLB Group&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, OLB has a 52-week high of $1.17 and a 52-week low of $0.28.

Why OLB Group Shares Are Popping Off

General

OLB Group shares are trading higher. The company announced its shareholders approve a 1-for-10 reverse split.

Stock Split

OLB Group Announces Its Shareholders Approved A Reverse Split Of Its Common Stock On A 1-For-10 Basis

Shares of Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) rose sharply in today's pre-market trading amid a rise in Bitcoin.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) prices gained around 1.5% over the past 24 hours to $66,012 this morning.
Riot Platforms shares gained 5.3% to $9.61 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) shares gained 64.1% to $0.7386 in pre-market trading. Complete Solaria responded to short attack with strong retail investor and Chairman support.</li>
<li>The OLB Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) gained 26.8% to $0.4348 in pre-market trading after dipping around 15% on Friday.</li>
<li>Tungray Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) gained 24.4% to $7.40 in pre-market trading after surging around 49% on Friday. The company priced its IPO at $4 per share.</li>
<li>Borealis Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLS#NASDAQ">BRLS</a>) climbed 19.4% to $4.75 in pre-market trading after falling more than 8% on Friday.</li>
<li>SuperCom Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) shares rose 17.5% to $0.2586 in pre-market trading after falling 8% on Friday. SuperCom, last week, priced a $2.9 million registered direct offering.</li>
<li>Assure Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONM#NASDAQ">IONM</a>) rose 15.8% to $0.51 in today's pre-market trading after dipping more than 30% on Friday.</li>
<li>T2 Biosystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) gained 15.5% to $3.42 in pre-market trading.</li>
<li>HWH International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWH#NASDAQ">HWH</a>) shares gained 14.4% to $1.51 in pre-market trading after jumping 29% on Friday. HWH International, during February, announced the acquisition of a café in Seocho-gu, South Korea.</li>
<li>GCT Semiconductor Holding, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NASDAQ">GCTS</a>) shares gained 12.5% to $4.39 in pre-market trading after falling around 22% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Vaxxinity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAXX#NASDAQ">VAXX</a>) fell 53.5% to $0.2215 in pre-market trading. Vaxxinity announced intention to voluntarily delist and deregister its Class A common stock from the Nasdaq.</li>
<li>Mingteng International Corporation Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) fell 17.5% to $3.05 in pre-market trading after gaining over 5% on Friday. Mingteng International, last week, priced its IPO at $4.00 per share.</li>
<li>AgriFORCE Growing Systems Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGRI#NASDAQ">AGRI</a>) declined 14.3% to $0.1402 in pre-market trading after gaining 9% on Friday. AgriForce Growing Systems was granted Australian patent number 2018215090 titled &#8220;High Fiber, High Protein, Low Carbohydrate Flour, Sweetened Liquid, Sweeteners, Cereals, And Methods For Production Thereof.&#8221;</li>
<li>Adlai Nortye Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANL#NASDAQ">ANL</a>) fell 14% to $10.66 in pre-market trading after gaining around 23% on Friday.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) fell 13.6% to $3.22 in pre-market trading after jumping over 100% on Friday. Top Wealth Group recently announced closing of initial public offering.</li>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) shares fell 12.8% to $6.00 in pre-market trading after declining 5% on Friday.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) shares fell 12.7% to $1.54 in pre-market trading after dipping 47% on Friday. Sunshine Biopharma's Nora Pharma received Health Canada approval for Niopeg.</li>
<li>Indonesia Energy Corporation Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INDO#NYSE">INDO</a>) shares declined 11.7% to $4.44 in pre-market trading after gaining 23% on Friday. Indonesia Energy, last month, filed for mixed shelf offering of up to $50 million.</li>
<li>Galiano Gold Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAU#NYSE">GAU</a>) fell 10.1% to $1.33 pre-market trading.</li>
<li>Markforged Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>) fell 8.8% to $0.62 pre-market trading after jumping around 16% on Friday.</li>
</ul>
Read More: <a href="https://www.benzinga.com/markets/equities/24/04/38351057/investor-sentiment-edges-lower-s-p-500-falls-for-sixth-straight-day">Investor Sentiment Edges Lower, S&amp;P 500 Falls For Sixth Straight Day</a>

$BTC

AGRI

AILE

BRLS

CSLR

GCTS

INDO

IONM

MKFG

MTEN

RIOT

SBFM

SPCB

TRSG

TTOO

Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

The Dow Jones index closed higher by around 400 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>OLB Group </h3>
<ul>
<li>The Trade: The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) Chairman and CEO Ronny Yakov <a href="https://www.benzinga.com/quote/OLB/analyst-ratings"> acquired a total of 784,212 shares </a> an average price of $0.77. To acquire these shares, it cost around $600,001. The company&rsquo;s Vice President Patrick Smith also acquired a total of 392106 shares.</li>
<li>What&rsquo;s Happening: The company, during November, posted a wider-than-expected quarterly loss.</li>
<li>What OLB Group Does: The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise.</li>
</ul>
<h3>OPKO Health</h3>
<ul>
<li>The Trade: OPKO Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opk#NASDAQ">OPK</a>) 10% owner Frost Gamma Investments Trust <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 500,000 shares at </a> at an average price of $0.98. To acquire these shares, it cost around $488,650.</li>
<li>What&rsquo;s Happening: OPKO Health recently priced private offering of $200 million convertible senior notes due 2029.</li>
<li>What OPKO Health Does: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/01/36690876/how-to-earn-500-a-month-from-at-t-stock-ahead-of-q4-print"> How To Earn $500 A Month From AT&amp;T Stock Ahead Of Q4 Print </a>
<h3>Tecogen </h3>
<ul>
<li>The Trade: Tecogen Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/tgen#OTC">TGEN</a>) Director John Hatsopoulos <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $0.73. The insider spent around $7,346 to buy those shares.</li>
<li>What&rsquo;s Happening: Tecogen, during November, announced an order for a 400-ton Tecochill unit from a large educational institution in Connecticut, facilitated by Clover Corp., a long-standing Manufacturers&rsquo; Representative for Tecogen.</li>
<li>What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production.</li>
</ul>

Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Long Ideas

Penny Stocks

Small Cap

Insider Trades

TGEN

OLB Group And 2 Other Stocks Under $1 Insiders Are Buying

Shares of SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) fell sharply during Wednesday&rsquo;s session after Keefe, Bruyette &amp; Woods <a href="https://www.benzinga.com/news/24/01/36470244/sofi-stock-is-sliding-wednesday-whats-going-on">downgraded rating on the stock</a>.
Keefe, Bruyette &amp; Woods analyst Michael Perito downgraded SoFi from a Market Perform rating to an Underperform rating and lowered the price target from $7.50 to $6.50, citing recent outperformance and a change in the analyst&#39;s model.
SoFi Technologies shares dipped 12.8% to $8.41 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) shares rose 150.8% to $6.14 after gaining over 6% on Tuesday.</li>
<li>Trinity Place Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tphs#NYSE">TPHS</a>) rose gained 62.6% to $0.1857. The company reported in 8K Filing, <a href="https://www.benzinga.com/money/mortgage-lenders-no-tax-returns/">mortgage</a> lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024.</li>
<li>Sigma Additive Solutions, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sasi#NASDAQ">SASI</a>) gained 60.3% to $4.65. Sigma Additive Solutions, announced in an 8-K Filing, the approval of the issuance of the shares of common stock in exchange for all the capital stock of NextTrip Holdings.</li>
<li>ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) jumped 58.3% to $1.90. ABVC BioPharma and its subsidiary received $460 million from AiBtl BioPharma as the first milestone payment of global licensing fees.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) rose 48.4% to $10.35. Sidus Space secured NOAA approval to provide imaging services to government and commercial customers.</li>
<li>Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) shares gained 32.8% to $0.97.</li>
<li>First Wave BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwbi#NASDAQ">FWBI</a>) shares gained 31.2% to $5.01. Roth MKM raised price target on the stock to $40.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltx#NASDAQ">ELTX</a>) gained 29% to $7.65.</li>
<li>TDCX Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdcx#NYSE">TDCX</a>) gained 28% to $6.18 after it disclosed receiving a preliminary non-binding acquisition offer.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) shares gained 27% to $5.14 after gaining 9% on Tuesday.</li>
<li>OneMedNet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onmd#NASDAQ">ONMD</a>) jumped 24% to $0.93. The company said OneMedNet iRWD(TM) is now available on AWS Data Exchange.</li>
<li>Hongli Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlp#NASDAQ">HLP</a>) rose 23.6% to $2.68.</li>
<li>Aeva Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aeva#NYSE">AEVA</a>) gained 19.3% to $0.8715. Aeva said that one of the top global automotive OEMs has selected Aeva as its Tier 1 LiDAR supplier for its series production vehicle program.</li>
<li>Dyne Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dyn#NASDAQ">DYN</a>) shares jumped 16.2% to $15.17. Dyne Therapeutics released initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.</li>
<li>Voyager Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vygr#NASDAQ">VYGR</a>) rose 16.1% to $10.45.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crev#NASDAQ">CREV</a>) rose 15.8% to $27.01.</li>
<li>Gaotu Techedu Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gotu#NYSE">GOTU</a>) rose 15.1% to $3.7601.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arwr#NASDAQ">ARWR</a>) gained 7% to $33.17. Arrowhead Pharmaceuticals reported pricing of offering of 15.79 million shares at $28.50 per share.</li>
<li>Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) gained 6.5% to $6.44. HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintained Anavex Life Sciences with a Buy and lowered the price target from $54 to $40.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>E-Home Household Service Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ejh#NASDAQ">EJH</a>) fell 60.2% to $1.52.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) shares fell 37.1% to $0.2886. RiskOn International, in partnership with Meetkai, announced the launch of &quot;askROI.com.&quot;</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) tumbled 35% to $0.8922.</li>
<li>Pinstripes Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pnst#NYSE">PNST</a>) shares fell 29.1% to $9.44 after surging 22% on Tuesday. Pinstripes and Banyan Acquisition Corporation announced they have closed their previously announced business combination, which was approved by Banyan&rsquo;s stockholders at a meeting on Dec. 27, 2023.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) dipped 25.5% to $2.1750 after the company announced a $125 million amendment to the collaboration with Japanese pharma company Daiichi Sankyo Co., Ltd.</li>
<li>Nemaura Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmrd#NASDAQ">NMRD</a>) fell 25.5% to $0.1403.</li>
<li>Peraso Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prso#NASDAQ">PRSO</a>) fell 22.4% to $7.33.</li>
<li>Taoping Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/taop#NASDAQ">TAOP</a>) fell 21.1% to $1.4830.</li>
<li>Kelso Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kiq#NASDAQ">KIQ</a>) fell 20.8% to $0.1814.</li>
<li>The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) declined 20.7% to $0.8001.</li>
<li>Signing Day Sports, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sgn#NYSE">SGN</a>) fell 20.7% to $0.8345 after declining around 7% on Tuesday.</li>
<li>Hallmark Financial Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hall#NASDAQ">HALL</a>) declined 20.6% to $0.9913.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) fell 18.5% to $2.55. TC BioPharm announced additional cost reduction steps to improve financial standing and streamline efficiencies.</li>
<li>Tenax Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenx#NASDAQ">TENX</a>) dipped 16.5% to $17.35.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) fell 15.3% to $216.00.</li>
<li>Porch Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prch#NASDAQ">PRCH</a>) fell 13.1% to $2.6405.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) shares fell 11.4% to $6.01 after gaining 25% on Tuesday.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) dipped 11.3% to $4.3250.</li>
<li>Sunrun Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/run#NASDAQ">RUN</a>) fell 11.1% to $17.30.</li>
<li>Addentax Group Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxg#NASDAQ">ATXG</a>) shares fell 10.8% to $1.3199.</li>
<li>Inspire Medical Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/insp#NYSE">INSP</a>) fell 10% to $169.13.</li>
<li>Livent Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lthm#NASDAQ">LTHM</a>) fell 9.8% to $16.26.</li>
<li>Polished.com Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pol#NYSE">POL</a>) fell 9.6% to $8.30 after jumping 52% on Tuesday.</li>
<li>Zoomcar Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcar#NASDAQ">ZCAR</a>) shares fell 9% to $2.72 after dipping around 19% on Tuesday.</li>
<li>Xerox Holdings Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NYSE">XRX</a>) fell 8.8% to $16.44.</li>
<li>Kohl&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kss#NYSE">KSS</a>) dipped 8.4% to $25.67.</li>
<li>UniFirst Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unf#NYSE">UNF</a>) fell 8.4% to $165.16 following first-quarter results.</li>
<li>Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) fell 7.9% to $3.9409. JMP Securities analyst Nicholas Jones maintained Opendoor Technologies with an Outperform and raised the price target from $3.5 to $5.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36470306/ethereum-falls-below-2-300-bonk-becomes-top-loser"> Ethereum Falls Below $2,300; Bonk Becomes Top Loser</a>

Intraday Update

ABVC

AEVA

ARWR

ATXG

AVXL

BREA

CREV

ELTX

ESPR

FWBI

GSX Techedu Inc. American Depositary Shares

GOTU

HALL

IFBD

INSP

LTHM

NEXI

NMRD

ONMD

OPEN

PNST

PRCH

PRSO

SASI

SIDU

SOFI

SPWR

TAOP

TCBP

TDCX

TENX

TPHS

VYGR

YOSH

ZCAR

ZJYL

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>OLB Group </h3>
<ul>
<li>The Trade: The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) Chairman and CEO Ronny Yakov <a href="https://www.benzinga.com/quote/OLB/analyst-ratings"> acquired a total of 22,315 shares </a> an average price of $0.75. To acquire these shares, it cost around $16,739.</li>
<li>What&rsquo;s Happening: On Nov. 15, the company posted a wider-than-expected quarterly loss.</li>
<li>What OLB Group Does: The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise.</li>
</ul>
<h3>Research Frontiers</h3>
<ul>
<li>The Trade: Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) Director Darryl Daigle <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 7,750 shares </a> at an average price of $0.97. To acquire these shares, it cost around $7,518.</li>
<li>What&rsquo;s Happening: On Nov. 2, Research Frontiers posted a narrower third-quarter loss.</li>
<li>What Research Frontiers Does: Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/12/36190200/how-to-earn-500-a-month-from-oracle-stock-after-q2-earnings-results"> How To Earn $500 A Month From Oracle Stock After Q2 Earnings Results </a>
<h3>Sadot Group </h3>
<ul>
<li>The Trade: Sadot Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdot#NASDAQ">SDOT</a>) Director David Errington <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $0.40. The insider spent around $3,986 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 14, Sadot Group posted upbeat quarterly sales.</li>
<li>What Sadot Group Does: Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China, and the Middle East/North Africa (MENA) region.</li>
</ul>
<h3>Forte Biosciences </h3>
<ul>
<li>The Trade: Forte Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fbrx#NASDAQ">FBRX</a>) Director Paul A Wagner <a href="https://www.benzinga.com/quote/ERAS/analyst-ratings"> acquired a total of 29,776 shares </a> at an average price of $0.65. The insider spent around $19,276 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 13, Forte Biosciences posted a wider third-quarter loss.</li>
<li>What Forte Biosciences Does: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (&quot;GvHD&quot;), vitiligo and alopecia areata (&quot;AA&quot;).</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

FBRX

REFR

SDOT

Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying

OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) reported its Q3 earnings results on Wednesday, November 15, 2023 at 10:15 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
OLB Gr missed estimated earnings by 300.0%, reporting an EPS of $-0.12 versus an estimate of $-0.03.
Revenue was up $3.44 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.05 which was followed by a 8.96% drop in the share price the next day.
Here's a look at OLB Gr's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.09</td>
<td>-0.11</td>
<td></td>
<td>-0.09</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.04</td>
<td>-0.17</td>
<td>-0.25</td>
<td>-0.12</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>7.53M</td>
<td>7.03M</td>
<td>8.20M</td>
<td>8.10M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>8.34M</td>
<td>6.62M</td>
<td>6.96M</td>
<td>6.25M</td>
</tr>
</tbody>
</table>

To track all earnings releases for OLB Gr <a href="https://www.benzinga.com/quote/OLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OLB Gr: Q3 Earnings Insights

OLB Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.03) by 300 percent. This is unchanged from the same period last year. The company reported quarterly sales of $9.69 million which beat the analyst consensus estimate of $6.56 million by 47.71 percent. This is a 55.11 percent increase over sales of $6.25 million the same period last year.

Earnings Beats

Earnings Misses

OLB Gr Q3 EPS $(0.12) Misses $(0.03) Estimate, Sales $9.69M Beat $6.56M Estimate

<h3>Gainers</h3>
<ul>
<li>Carbon Revolution Public Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crev#NASDAQ">CREV</a>) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company&rsquo;s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.</li>
<li>Sensei Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snse#NASDAQ">SNSE</a>) shares rose 25.8% to $0.8686 in pre-market trading. Sensei Biotherapeutics reported clinical data for SNS-101 at 2023 SITC Annual Meeting.</li>
<li>Digital Brands Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbgi#NASDAQ">DBGI</a>) shares gained 21.7% to $5.28 in pre-market trading after falling around 4% on Friday.</li>
<li>Warrantee Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrnt#NASDAQ">WRNT</a>) rose 21.4% to $0.45 in pre-market trading after gaining 11% on Friday.</li>
<li>RiceBran Technologies (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ribt#NASDAQ">RIBT</a>) shares climbed 21% to $0.4744 in pre-market trading after gaining 7% on Friday.</li>
<li>POSCO Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pkx#NYSE">PKX</a>) shares jumped 18.1% to $98.51 in pre-market trading. Shares of South Korea ADRs and ETFs gained following government ban on short selling through first half of next year.</li>
<li>Near Intelligence, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nir#NASDAQ">NIR</a>) rose 16.7% to $0.1997 in pre-market trading after gaining over 10% on Friday.</li>
<li>SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) shares rose 16.7% to $1.12 in pre-market trading. SELLAS Life Sciences recently announced a $4 million registered direct offering.</li>
<li>Missfresh Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mf#NASDAQ">MF</a>) gained 14.1% to $0.89 in pre-market trading after falling around 6% on Friday.</li>
<li>BEST Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/best#NYSE">BEST</a>) shares rose 12.1% to $2.68 in pre-market trading. BEST announced receipt of a preliminary non-binding proposal to acquire the company.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) dipped 16.8% to $0.5737 in pre-market trading.</li>
<li>Benson Hill, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhil#NYSE">BHIL</a>) shares fell 16.5% to $0.3333 in pre-market trading after surging 58% on Friday.</li>
<li>ADC Therapeutics SA (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adct#NYSE">ADCT</a>) shares fell 16% to $0.6720 in pre-market trading after jumping 14% on Friday.</li>
<li>Affimed N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afmd#NASDAQ">AFMD</a>) shares fell 13.2% to $0.3166 in pre-market trading after gaining 4% on Friday.</li>
<li>Collective Audience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caud#NASDAQ">CAUD</a>) fell 13.2% to $5.46 in pre-market after falling around 77% on Friday.</li>
<li>Mangoceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgrx#NASDAQ">MGRX</a>) shares fell 11.4% to $0.5228 in pre-market trading.</li>
<li>Monopar Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnpr#NASDAQ">MNPR</a>) shares fell 10.8% to $0.4550 in pre-market trading.</li>
<li>The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) fell 10.1% to $0.5486 in pre-market trading.</li>
<li>Acurx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acxp#NASDAQ">ACXP</a>) fell 9.5% to $2.97 in pre-market trading after declining around 14% on Friday.</li>
<li>Astra Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astr#NASDAQ">ASTR</a>) shares fell 8.5% to $0.84 in pre-market trading. Astra Space is expected to report financial results for its third quarter after market close on Nov. 13, 2023.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/11/35612701/teradata-likely-to-report-higher-q3-earnings-heres-a-look-at-recent-price-target-changes-by-the-mos"> Teradata Likely To Report Higher Q3 Earnings; Here&#39;s A Look At Recent Price Target Changes By The Most Accurate Analysts</a>

ACXP

ADCT

AFMD

ASTR

BEST

BHIL

CAUD

DBGI

MGRX

MNPR

RIBT

SNSE

WRNT

Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
OLB Gr (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) just reported results for the fourth quarter of 2023.<ul><li>OLB Gr reported earnings per share of -31 cents.</li><li>The company reported revenue of $5.91 million.</li><li>This was 20.66% worse than the analyst estimate for revenue of $7.45 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/olb-stock-earnings-olb-gr-for-q4-of-2023/">OLB Stock Earnings: OLB Gr Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OLB Stock Earnings: OLB Gr Misses Revenue for Q4 2023

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start off the trading week with a look at the biggest pre-market stock movers for Monday morning!



Moving stocks this morning are earnings, investments, a delisting and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is rocketing more than 67% on approval for its <a href="https://www.nasdaq.com/press-release/moolec-becomes-first-molecular-farming-company-to-achieve-usda-approval-for-plant">plant-groan animal proteins</a>.</li>



<li>OLB Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) shares are soaring over 46% with heavy pre-market trading.</li>



<li>Complete Solaria (NASDAQ:<a href="https://investorplace.com/stock-quotes/cslr-stock-quote/">CSLR</a>) stock is surging more than 42% <a href="https://www.nasdaq.com/press-release/retail-stock-sector-and-chairman-t.j.-rodgers-invest-in-complete-solaria-2024-04-21">on investment news</a>.</li>



<li>SuperCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/spcb-stock-quote/">SPCB</a>) shares are gaining over 33% ahead of its <a href="https://www.nasdaq.com/press-release/supercom-to-report-fourth-quarter-and-full-year-2023-financial-results-on-april-22">Q4 2023 earnings report</a> this morning.</li>



<li>Dermata Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/">DRMA</a>) stock is rising more than 18% on Monday morning.</li>



<li>Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) shares are increasing over 17% without any clear news this morning.</li>



<li>Palisade Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/pali-stock-quote/">PALI</a>) stock is climbing more than 16% despite a lack of news today.</li>



<li>Global Gas (NASDAQ:<a href="https://investorplace.com/stock-quotes/hgas-stock-quote/">HGAS</a>) shares are heading over 14% higher on Monday.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is jumping more than 13% on Monday morning.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) shares are up over 13% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Vaxxinity (NASDAQ:<a href="https://investorplace.com/stock-quotes/vaxx-stock-quote/">VAXX</a>) stock is crashing more than 55% on the company&rsquo;s <a href="https://finance.yahoo.com/news/vaxxinity-announces-intention-voluntarily-delist-202700884.html">plans to delist its shares</a>.</li>



<li>EzFill (NASDAQ:<a href="https://investorplace.com/stock-quotes/ezfl-stock-quote/">EZFL</a>) shares are plummeting close to 37% this morning.</li>



<li>Hepion Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/hepa-stock-quote/">HEPA</a>) stock is diving over 29% on plans to <a href="https://www.nasdaq.com/press-release/hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial">wind down a clinical trial</a>.</li>



<li>iLearningEngines (NASDAQ:<a href="https://investorplace.com/stock-quotes/aile-stock-quote/">AILE</a>) shares are tumbling more than 21% after <a href="https://finance.yahoo.com/news/ilearningengines-inc-becomes-publicly-traded-200500132.html">going public last week</a>.</li>



<li>Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock is taking an over 15% beating <a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">after a recent rally</a>.</li>



<li>Biophytis (NASDAQ:<a href="https://investorplace.com/stock-quotes/bpts-stock-quote/">BPTS</a>) shares are sliding more than 15% ahead of <a href="https://www.nasdaq.com/press-release/biophytis-announces-ratio-change-under-its-american-depositary-receipt-adr-program-0">a ratio change tomorrow</a>.</li>



<li>Adlai Nortye (NASDAQ:<a href="https://investorplace.com/stock-quotes/anl-stock-quote/">ANL</a>) stock is dropping nearly 15% today.</li>



<li>BioSig Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/bsgm-stock-quote/">BSGM</a>) shares are falling over 13% this morning.</li>



<li>Sunshine Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/sbfm-stock-quote/">SBFM</a>) stock is decreasing more than 12% today.</li>



<li>Indonesia Energy (NYSEMKT:<a href="https://investorplace.com/stock-quotes/indo-stock-quote/">INDO</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Vaxxinity&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vaxx-stock-quote/">VAXX</a>) stock is falling hard on Monday after the biotechnology company announced plans to <a href="https://finance.yahoo.com/news/vaxxinity-announces-intention-voluntarily-delist-202700884.html">voluntarily delist its shares</a> from the Nasdaq Exchange.



Vaxxinity&nbsp;will file to delist its shares on April 29, 2024. The company expects this to result in its final day of trading on the Nasdaq Exchange being May 9, 2024.



Vaxxinity&nbsp;is voluntarily delisting its shares due to a delisting notice it received in February. This gave the company until Aug. 7, 2024 to get its share price back above the $1 minimum required for compliance.



However, Vaxxinity&nbsp;is delisting its shares early to reduce its obligations. It notes that this will save money compared to staying on the exchange.



<h2>What That Means for VAXX Stock</h2>



Just because Vaxxinity is voluntarily delisting its shares doesn&rsquo;t mean the stock will disappear. Instead, the company expects its shares to trade on the OTC Markets after May 9.



VAXX stock is down 58% as of Monday morning with more than 278,000 shares traded. That&rsquo;s still below its daily average trading volume of about 447,000 shares.



Investors seeking out even more of the most recent stock market stories are going to want to stick around!



We have all of the hottest stock market stories that traders need to know about on Monday! A few examples include why shares of OLB Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) and Moolec Science&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock are up today. As well as the biggest pre-market stock movers this morning. All of this info is ready to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-olb-group-olb-stock-up-27-today/">Why Is OLB Group (OLB) Stock Up 27% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-moolec-science-mlec-stock-up-121-today/">Why Is Moolec Science (MLEC) Stock Up 121% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-22nd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-vaxxinity-vaxx-stock-down-58-today/">Why Is Vaxxinity (VAXX) Stock Down 58% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Vaxxinity (VAXX) Stock Down 58% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
OLB Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) stock is heading higher on Monday alongside heavy pre-market trading of the transaction processing services company&rsquo;s shares this morning.



As of this writing, more than 1.9 million shares of OLB stock have changed hands. That&rsquo;s already well above the company&rsquo;s daily average trading volume of only about 53,000 shares.



This movement comes without any news from OLB Group. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC). There&rsquo;s also no new analyst coverage that explains the OLB stock rally this morning.



What is worth noting is OLB&rsquo;s status as a penny stock. This comes from its low daily average trading volume, prior closing price of 33 cents per share and its market capitalization of only $5.971 million.



<h2>What That Means for OLB Stock Today</h2>



Being a penny stock opens OLB shares up to certain vulnerabilities. That includes volatility as certain types of traders try to manipulate the stock. This could be what&rsquo;s happening this morning considering the lack of news and heavy trading.



Keeping that in mind, this makes OLB stock a risky investment today. It might not be long before the pump ends and the dump begins.



OLB stock is up 27.2% as of Monday morning. However, the shares were down 67% year-to-date when markets closed on Friday.



We have even more stock market stories traders will want to read about today!



InvestorPlace is home to all of the hottest stock market news for Monday! Among that is what has shares of Moolec Science&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock up, the biggest pre-market stock movers this morning and more. All of this info is ready to go at the following links!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-moolec-science-mlec-stock-up-121-today/">Why Is Moolec Science (MLEC) Stock Up 121% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-22nd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>



<li><a href="https://investorplace.com/2024/04/will-bitcoin-go-up-after-the-april-2024-halving-3-expert-predictions/">Will Bitcoin Go Up After the April 2024 Halving? 3 Expert Predictions</a></li>
</ul>On <a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a> and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-olb-group-olb-stock-up-27-today/">Why Is OLB Group (OLB) Stock Up 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is OLB Group (OLB) Stock Up 27% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Hepion Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/hepa-stock-quote/">HEPA</a>) stock is diving on Monday after the biopharmaceutical company announced plans to <a href="https://www.nasdaq.com/press-release/hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial">wind down a clinical trial</a>.



A press release from the company notes that it is winding down it Phase 2b ASCEND-NASH study. The failure of the study comes as it couldn&rsquo;t reach the planned 336 patients. Instead, it only got to 151 patients.



On top of this, Hepion Pharmaceuticals is struggling with resources as the company is exploring strategic alternatives. This didn&rsquo;t leave it with enough room to keep the trial going while waiting for more patients to enroll.



Hepion Pharmaceuticals executive chairman John Brancaccio said the following about the news.




&ldquo;We are disappointed to announce the wind-down of our Phase 2 NASH trial, which we attribute entirely to resource constraints. Given the number of enrolled NASH patients to date and the low probability of generating relevant efficacy data to support a registrational trial with our current cash resources, we have opted to wind down the program and assure that patients are transitioned out of the trial in a safe and compliant manner.&rdquo;




<h2>HEPA Stock Movement Today</h2>



With this news comes a 40.5% drop for HEPA stock on Monday morning. Investors will note that the shares were already down 36.2% year-to-date when markets closed on Friday.



This also comes with around 39,000 shares traded. The company&rsquo;s daily average trading volume is still above that at 75,000 shares.



Investors will find even more of the most recent stock market stories ready to go below!



We are offering insight into the top stock market news for Monday! That includes everything happening with shares of Vaxxinity&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vaxx-stock-quote/">VAXX</a>) stock, OLB Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) stock and Moolec Science&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock today. You can find out more on these matters at the following links!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-vaxxinity-vaxx-stock-down-58-today/">Why Is Vaxxinity (VAXX) Stock Down 58% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-olb-group-olb-stock-up-27-today/">Why Is OLB Group (OLB) Stock Up 27% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-moolec-science-mlec-stock-up-121-today/">Why Is Moolec Science (MLEC) Stock Up 121% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-hepion-pharmaceuticals-hepa-stock-down-41-today/">Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday!



Moving shares are earnings, public offerings, acquisition deals and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>ReAlpha Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/aire-stock-quote/">AIRE</a>) stock is rocketing more than 59% after <a href="https://www.nasdaq.com/press-release/realpha-tech-corp.-completes-the-acquisition-of-naamche-2024-05-06">completing its acquisition of Naamche</a>.</li>



<li>Esperion Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/espr-stock-quote/">ESPR</a>) shares are soaring over 26% alongside its <a href="https://www.globenewswire.com/news-release/2024/05/07/2876454/0/en/Esperion-Reports-First-Quarter-2024-Financial-Results.html">Q1 earnings report</a>.</li>



<li>FibroGen (NASDAQ:<a href="https://investorplace.com/stock-quotes/fgen-stock-quote/">FGEN</a>) stock is surging more than 22% with the release of its <a href="https://www.nasdaq.com/press-release/fibrogen-reports-first-quarter-2024-financial-results-2024-05-06">Q1 earnings results</a>.</li>



<li>American Strategic Investment&nbsp; (NYSE:<a href="https://investorplace.com/stock-quotes/nyc-stock-quote/">NYC</a>) shares are rising over 22% <a href="https://www.nasdaq.com/press-release/bellevue-capital-partners-llc-launches-tender-offer-for-shares-of-american-0">with a tender offer for its shares</a>.</li>



<li>Zeta Global (NYSE:<a href="https://investorplace.com/stock-quotes/zeta-stock-quote/">ZETA</a>) stock is increasing more than 18% after <a href="https://seekingalpha.com/article/4689896-zeta-global-holdings-corp-2024-q1-results-earnings-call-presentation?source=content_type%3Areact%7Cfirst_level_url%3Ahome%7Csection%3Alatest_articles%7Csection_asset%3Alatest_articles%7Cline%3A2">releasing Q1 earnings results</a>.</li>



<li>Fundamental Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/fgf-stock-quote/">FGF</a>) shares are climbing over 16% <a href="https://www.nasdaq.com/press-release/fundamental-global-inc.-announces-acquisition-of-strong-mdi-screen-systems-inc.-by-fg">following an acquisition</a>.</li>



<li>Unusual Machines (NYSEMKT:<a href="https://investorplace.com/stock-quotes/umac-stock-quote/">UMAC</a>) stock is heading more than 16% higher on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318294419&amp;type=PDF&amp;symbol=UMAC&amp;cdn=25e5a813f1372370db145821db848236&amp;companyName=Unusual+Machines+Inc.&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-05-06">an update to its leadership contract</a>.</li>



<li>OLB Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) shares are jumping over 14% following a <a href="https://www.nasdaq.com/press-release/the-olb-group-inc.-announces-one-for-ten-reverse-stock-split-2024-05-02">reverse stock split</a>.</li>



<li>Hims &amp; Hers Health (NYSE:<a href="https://investorplace.com/stock-quotes/hims-stock-quote/">HIMS</a>) stock is gaining more than 14% on <a href="https://finance.yahoo.com/video/him-hers-health-stock-soars-213839945.html">strong Q1 revenue</a>.</li>



<li>Ambac Financial (NYSE:<a href="https://investorplace.com/stock-quotes/ambc-stock-quote/">AMBC</a>) shares are up over 14% alongside <a href="https://www.nasdaq.com/press-release/ambac-reports-first-quarter-2024-results-2024-05-06">Q1 2024 earnings</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>GreenPower Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/gp-stock-quote/">GP</a>) stock is diving more than 34% after <a href="https://www.nasdaq.com/press-release/greenpower-announces-pricing-of-us%242.3-million-underwritten-public-offering-2024-05">pricing a public offering</a>.</li>



<li>AgriFORCE Growing (NASDAQ:<a href="https://investorplace.com/stock-quotes/agri-stock-quote/">AGRI</a>) shares are tumbling over 30% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318295411&amp;type=PDF&amp;symbol=AGRI&amp;cdn=92eccca362a5189b8a5d6137d58b5c46&amp;companyName=AgriFORCE++Growing+Systems+Ltd.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-05-06">proposed public offering</a>.</li>



<li>Actelis Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/asns-stock-quote/">ASNS</a>) stock is falling more than 18% without any clear news this morning.</li>



<li>Helius Medical Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/hsdt-stock-quote/">HSDT</a>) shares are taking an over 17% beating after <a href="https://www.nasdaq.com/press-release/helius-medical-technologies-inc.-announces-pricing-of-%246.4-million-public-offering">pricing a public offering</a>.</li>



<li>Holdco Nuvo (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuvo-stock-quote/">NUVO</a>) stock is dropping more than 15% following a massive rally yesterday.</li>



<li>Celsius (NASDAQ:<a href="https://investorplace.com/stock-quotes/celh-stock-quote/">CELH</a>) shares are sliding over 15% after <a href="https://www.nasdaq.com/press-release/celsius-holdings-reports-first-quarter-2024-financial-results-2024-05-07">releasing its Q1 2024 results</a>.</li>



<li>Integrated Media Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/imte-stock-quote/">IMTE</a>) stock is decreasing more than 13% despite a lack of news today.</li>



<li>Lyra Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyra-stock-quote/">LYRA</a>) stock is slipping over 13% as <a href="https://investorplace.com/2024/05/why-is-lyra-therapeutics-lyra-stock-down-90-today/">a failed trial</a> continues to pull it down.</li>



<li>Teradata (NYSE:<a href="https://investorplace.com/stock-quotes/tdc-stock-quote/">TDC</a>) shares are dipping more than 12% <a href="https://finance.yahoo.com/news/teradata-corp-tdc-q1-2024-213642057.html">on mixed earnings</a>.</li>



<li>Strong Global (NYSEMKT:<a href="https://investorplace.com/stock-quotes/sge-stock-quote/">SGE</a>) stock closes out our pre-market stock movers down over 12% <a href="https://investorplace.com/2024/05/why-is-strong-global-entertainment-sge-stock-up-58-today/">following a rally yesterday</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-may-7th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
OLB Gr (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) just reported results for the first quarter of 2024.<ul><li>OLB Gr reported earnings per share of -14 cents.</li><li>The company reported revenue of $3.50 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/olb-stock-earnings-olb-gr-for-q1-of-2024/">OLB Stock Earnings: OLB Gr Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OLB Stock Earnings: OLB Gr Reported Results for Q1 2024

The OLB Group files for $75 million mixed shelf offering

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
OLB Gr (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) just reported results for the second quarter of 2024.<ul><li>OLB Gr reported earnings per share of -$1.49.</li><li>The company reported revenue of $3.52 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/olb-stock-earnings-olb-gr-for-q2-of-2024/">OLB Stock Earnings: OLB Gr Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OLB Stock Earnings: OLB Gr Reported Results for Q2 2024

The OLB Group GAAP EPS of -$1.49, revenue of $3.5M

AIRE

AMBC

ASNS

BPTS

BSGM

CELH

DRMA

EZFL

FGEN

GRTX

HEPA

HGAS

HIMS

HSDT

IMTE

LYRA

MLEC

NUVO

PALI

PRTG

RWOD

SOAR

UMAC

ZETA

Screenshot 2024-05-09 at 5.54.20 PM

Fintech news covering the emerging Financial Technology services sector

Fintech

This Fintech Is Now Serving The Underbanked

Screenshot 2024-04-09 at 5.36.58 PM

Emerging Markets

Bodegas Are The New Frontier For Underbanked Communities – OLB Group Leading The Charge

Screenshot 2024-03-25 at 5.51.15 PM

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

OLB Group (NASDAQ: OLB) Preparing For Strategic Spinoff Of DMint Subsidiary To OLB Shareholders

Screenshot 2024-02-28 at 6.30.08 PM

Movers & Shakers

OLB Group Is Making Omnicommerce And Wireless Plans Accessible To The Underbanked And Revolutionizing Payments For Businesses

OLB Group (NASDAQ: OLB) Preparing for    Strategic Spinoff Of DMint Subsidiary to OLB Shareholders

Press Releases

OLB Group to Conduct Fourth Quarter and 2023 Annual Report Call Today, April 15

OLB Group Provides Shareholder Update Prior to Upcoming Special Shareholder Meeting April 26, 2024, at 10:00 AM Eastern

Legal

OLB Group Regains Compliance with Nasdaq Minimum Bid Price Requirement

OLB Group Announces Financial Results for First Quarter, 2024

Comments

OLB Gr

Notizie

Ultime notizie per OLB Gr (NASDAQ:OLB) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO